leisure time -WSS

leisure time

author：entertainment 2025-10-02 22:57:37 - browse：7584

Have you ever seen a mouse with a set of muscles more appropriate for a bodybuilder or comic book superhero?

Well, 25 years ago, researchers at Johns Hopkins University made it happen. By silencing a gene responsible for producing a protein called myostatin, they directed tiny mouse bodies to grow double the amount of lean muscle they would normally, leading to mice with bulky arms, defined pectorals, and an overall more substantial body mass. They were dubbed “mighty mice.”

Now, biotech startups are hoping to use those findings to create what they believe will be better weight loss medications. In the last several months, multiple companies have disclosed they are testing drugs that preserve or grow muscle while reducing fat, as shown in the updated STAT Obesity Drug Tracker. They hope that their drugs, possibly when used in conjunction with existing obesity treatments, will result in healthier weight loss.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： There’s a way to spot data fakery. All journals should be using it

WSS

Exact Sciences stock tumbles despite strong cancer detection sales

The stock market has soared this year, but will it last? Experts weigh in

Readout Newsletter: Novavax stock, FogPharma, Novo Nordisk

Sanders wants to replace patents with prizes for drug inventions

After a decade, new Gardasil ad campaign gets it (mostly) right

The stock market has soared this year, but will it last? Experts weigh in

hotspot

leisure time

knowledge

Supreme Court strikes down use of affirmative action

In rare move, senator releases unverified FBI source report alleging Biden bribe

Duchenne breakthrough therapy leaves behind pioneering families

Headers linked to memory issues, raising questions about soccer safety as the World Cup kicks off

Medicare details structure of new drug price negotiation program

How a Boston hospital is priming medical residents to use GPT

DIEP, the 'gold standard' of breast reconstruction, is under threat

A woman pleads guilty to fire that kept a Wyoming abortion clinic from opening for a year

Novavax promises a turnaround & Lilly roils the obesity market

'Golden Bachelor' Gerry Turner reveals what he wants in a partner and more

hotspot

Jan. 6 charges against Trump would add to his mounting legal peril as he campaigns for 2024

Headers linked to memory issues, raising questions about soccer safety as the World Cup kicks off

FTC falls short on scrutinizing hospital mergers, study says

Why rehabilitation engineers need to center patients in their research

Judge denies Trump's request for new trial in E. Jean Carroll case

Cell therapy fails to slow type 1 diabetes, but safety is established

explore

entertainment

explore

focus